StockDrifts LogoStockDrifts

Ilshin Bio 068330

Company
일신바이오Ilshin Bio
Insiders
2
Buys
4
Total Value
₩777M ($539K)
Avg Return
-10.77%
Last Filing
2026-06-02

Ilshin Bio (068330) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩777M ($539K) in reported transaction value. The earliest filing StockDrifts holds for Ilshin Bio is dated 2020-08-14; the most recent is 2026-06-02. Across these filings the average return since disclosure is -10.77%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-02BUYMarket Buy
홍중기
Hong Joong-ki
moving394.8K₩1,168+0.0%₩461M ($320K)
2026-05-14BUYMarket Buy
홍중기
Hong Joong-ki
moving142.6K---
2024-07-23BUYMarket Buy
홍성대
Hongseongdae
CEO69.5K₩1,256+31.5%₩87M ($61K)
2020-08-14BUYMarket Buy
홍중기
Hong Joong-ki
moving50.0K₩4,570-63.9%₩229M ($159K)

Frequently asked questions

Who has been buying Ilshin Bio stock?
2 distinct insiders have filed 4 disclosed insider purchases in Ilshin Bio (068330), most recently on 2026-06-02. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Ilshin Bio have?
Ilshin Bio has 4 buy-side and 0 sell-side disclosures on record, covering ₩777M ($539K) in total reported value, spanning 2020-08-14 to 2026-06-02.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.